Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases

Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases
复制标题

DOI:
10.1258/jrsm.2009.090027
复制
发表时间:
2009-10-01
影响因子:
17.3
通讯作者:
Sheikh, A.
Sheikh, A.
中科院分区:
医学2区
文献类型:
--
作者:
Anandan, C.;Gupta, R.;Sheikh, A.

文献摘要

被引文献

相似文献

背景在苏格兰,人们对向过敏性疾病患者提供的护理质量持续感到担忧,但关于总体疾病负担的可靠数据相对较少。我们试图:(1)描述过敏性疾病的发病率、患病率和结局;(2)估计医疗负担和费用;(3)调查苏格兰流行病学的种族差异和过敏性疾病的结果。方法数据来源:全国调查;初级保健数据;处方和药物数据;住院数据和死亡率数据。结果过敏性疾病在苏格兰非常常见,大约三分之一的人在一生中的某个时候受到影响。湿疹的发病率最高(每1000名登记患者中有10.2人)。超过4%的全科医生会诊和1.5%的住院治疗是由于过敏性疾病。2005年有100人死于哮喘(每百万人中有20人)。过敏性疾病每年的直接医疗费用估计为1.3亿英镑,其中大部分发生在初级保健中,与哮喘有关。结论过敏性疾病在苏格兰很常见,鉴于目前受影响的儿童比例非常高,与这些疾病相关的高疾病负担可能会持续数十年。
Background There are ongoing concerns about the quality of care provided to patients with allergic disorders in Scotland, but there are relatively few reliable data on the overall disease burden. We sought to: (1) describe the incidence, prevalence and outcome of allergic disorders; (2) estimate healthcare burden and costs; and (3) investigate ethnic variations in the epidemiology and outcomes from allergic disorders in Scotland.Methods Data sources: national surveys; primary care data; prescribing and medication data; hospital admissions data and mortality data.Results Allergic disorders are extremely common in Scotland, affecting about one in three of the population at some time in their lives. Incidence was highest for eczema (10.2 per 1000 registered patients). Over 4% of all GP consultations and 1.5% of hospital admissions were for allergic disorders. There were 100 asthma deaths in 2005 (20 per million people). Direct healthcare costs for allergic disorders were an estimated 130 pound million per year, the majority of these being incurred in primary care and related to asthma.Conclusions Allergic disorders are common in Scotland and given the very high proportion of children now affected, the high disease burden associated with these conditions is likely to persist for many decades.